Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broccoli Sprout Extracts in Healthy Volunteers
NCT02023931Phase 1Completed
- Start
- Mar 2014
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of broccoli seed and sprout extract in head and neck squamous cell carcinoma (HNSCC). Primary endpoint: Modulation of Nrf2 pathway biomarkers (NQO1, GSTs, AKRs) in oral mucosa at 11 weeks. Started Mar 2014; status: completed.
02
Drugs
broccoli seed and sprout extract
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02023931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02023931.